|
Intas Pharmaceuticals IPO (CARE) CARE IPO Grade |
| Date | Rating | Target Price | Recommendation Price | Broker house | | 28 Jul 2011 | 4/5 | -- | -- | CARE Report | |
|
Intas Pharmaceuticals IPO (ICRA) ICRA grading |
| Date | Rating | Target Price | Recommendation Price | Broker house | | 26 Jul 2011 | 4/5 | -- | -- | ICRA Report | |
|
Intas Pharmaceuticals IPO (ICRA) ICRA grading |
| Date | Rating | Target Price | Recommendation Price | Broker house | | 26 Jul 2011 | 4/5 | -- | -- | ICRA Report | |
|
Intas Pharmaceuticals IPO (ICRA) Doc 1 |
|
ICRA Grading Feature | Date | Rating | Target Price | Recommendation Price | Broker house | | 26 Jul 2011 | 4/5 | -- | -- | ICRA Report | |
|
Intas Pharmaceuticals IPO (ICRA) Doc 2 |
|
ICRA Grading Feature | Date | Rating | Target Price | Recommendation Price | Broker house | | 26 Jul 2011 | 4/5 | -- | -- | ICRA Report | |
|
intas pharma ipo (SEBI) DRHP |
| Date |
Rating |
Target Price |
Recommendation Price |
Broker house |
| 29 Mar 2011 |
-- |
-- |
-- |
SEBI Report |
Reports.DesiStockResearch.com |
|
intas pharma ipo (SEBI) DRHP @ Kotak |
| Date |
Rating |
Target Price |
Recommendation Price |
Broker house |
| 28 Mar 2011 |
-- |
-- |
-- |
SEBI Report |
Reports.DesiStockResearch.com |
|
Intas Pharmaceuticals IPO (info) |
Intas Pharmaceuticals plans to raise approx Rs 750 Cr thu an IPO and allow PE investor ChrysCapital to partly exit. This will value the company at over Rs. 5,000 Cr.
Reports.DesiStockResearch.com |
